SEC Form 4 · accession 0001214659-18-003245
Vyome Holdings, Inc · HIND
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew P Rasdal
Officer — President & CEO · Director
Period of report
Apr 30, 2018
Accepted (ET)
May 2, 2018 · 7:23 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001427570
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 30, 2018 | A | 2,987 | $3.27 | A | 457,058 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were acquired under the Obalon Therapeutics, Inc. 2016 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).